Lykos
Payments companies reported to CMS as associated with Lykos. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lykos, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lykos
These are the largest totals companies reported as associated with Lykos. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaime Shamonki | Santa Monica, CA | Anatomic Pathology & Clinical Pathology | $295.33 |
| Mark Amols | Mesa, AZ | Reproductive Endocrinology | $158.96 |
| Kaylen Silverberg | Austin, TX | Reproductive Endocrinology | $132.42 |
| Paul Magarelli | Denver, CO | Reproductive Endocrinology | $102.17 |
| Violet Klenov | Creve Coeur, MO | Reproductive Endocrinology | $76.62 |
| Pietro Bortoletto | Boston, MA | Reproductive Endocrinology | $69.07 |
| Armando Arroyo | Worcester, MA | Reproductive Endocrinology | $67.02 |
| Molina Dayal | St. Louis, MO | Reproductive Endocrinology | $56.19 |
| Peter Ahlering | Saint Louis, MO | Reproductive Endocrinology | $55.08 |
| Mira Aubuchon | Chesterfield, MO | Obstetrics & Gynecology | $55.08 |
Prescribed Lykos?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.